If you have a project where you want to validate novel therapeutic strategies, CQMED can utilize a wide range of tools. Do you have a hint that modulation of a given protein will satisfy an unmet medical need? At CQMED we can partner to develop potent and selective small-molecule tool compound and to test your hypothesis in a biologically relevant model. Not sure how to do early-stage drug discovery? We can help.
Who can be our partner?
- Academic labs with interests in structural biology/medicinal chemistry projects for understudied proteins.
- Pharmaceutical companies located in Brazil which have an interest in projects including structural biology/medicinal chemistry for disease-related proteins.
How to Become our Partner?
Describe your main question with a short text about your scientific background and Email us at cqmed@unicamp.br.
Which models can we use to work together?
- Academic Professors – any group can submit a protein target of interest for a joint project according to the INCT criteria (below) for generating a target enabling package (TEP) . The duration of each project and the aims should be defined at the beginning of the project. The academic partners need to appoint a member of their group to come and execute most of the experiments at CQMED.
- Contact Katlin Massirer (katlinbm@gmail.com)
- Industry – leaders in R&D of pharmaceutical Industry or other companies can contract projects with us in the field of medicinal chemistry or biotechnology by following the EMBRAPII model, where the University plus the Embrapii agency will contribute with 45% of the funding while the company will contribute with ~ 42%. The duration of the projects can vary from 2-6 years and the execution of the project will be split between our team of postdocs and the company according to the expertise, resources and strategy.
- Private pharmaceutical companies – contact cqmed@unicamp.br